You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

15 search results for: remission

What Could <b>Remission</b> Mean in AD?
expert video

What Could Remission Mean in AD?

Dermatology
Dr. Simpson explores the concept of remission in AD, focusing on minimal disease activity and long-term remission, discussing how disease modification in AD can impact the course of the disease and its associated comorbidities.
View more
On-Treatment Clinical <b>Remission</b> in Asthma Patients Case Tool
interactivity

On-Treatment Clinical Remission in Asthma Patients Case Tool

Pulmonology
Review a severe asthma patient case to learn more about assessing asthma control and on-treatment clinical remission.
View more
EAACI 2024 Moving Beyond Control To On-Treatment Clinical <b>Remission</b>
expert video

EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission

Pulmonology
Watch Prof G. Walter Canonica discuss the need to move beyond disease control to clinical remission in asthma and CRSwNP.
View more
ADVENT On Air | The Road Ahead: Achieving <b>Remission</b> for ​Patients With Asthma
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
Current systemic therapies have been shown to induce <b>remission</b> in a subset of AD patients
expert video

Current systemic therapies have been shown to induce remission in a subset of AD patients

Dermatology
Dr. Ramien discusses evidence suggesting early targeted inhibition in pediatric patients may prevent disease progression or lead to remission.
View more
The Impact of Advanced Systemic Therapies on Disease Control and Potential <b>Remission</b> in Atopic Dermatitis
expert video

The Impact of Advanced Systemic Therapies on Disease Control and Potential Remission in Atopic Dermatitis

Dermatology
Exploring the concept ​of disease modification relating to therapeutic interventions with targeted systemic therapies in atopic dermatitis​.
View more
Evolving Topics in Type 2 Inflammation
expert video

Evolving Topics in Type 2 Inflammation

Type 2 Inflammation
Drs. Eric Simpson, Jonathan Spergel, and Profs. Francesca Puggioni, Ian Pavord, Peter Hellings discuss emerging topics in type 2 inflammatory diseases
View more
ADVENT On Air | Charting a New Course: The Frontier of Early Intervention and Disease Modification in AD
Podcast

ADVENT On Air | Charting a New Course: The Frontier of Early Intervention and Disease Modification in AD

Dermatology
Join Drs. April Armstrong and Lisa Beck for a conversation around the long-term burden and effects of AD. They will discuss the underlying pathophysiology of AD and how early intervention and disease modification may impact disease course.
View more
New Perspectives on Disease Modification in Atopic Dermatitis - Panel Discussion
expert video

New Perspectives on Disease Modification in Atopic Dermatitis - Panel Discussion

Dermatology
Panel discussion exploring what disease modification could involve in atopic dermatitis.
View more
New Perspectives on Disease Modification in Atopic Dermatitis
expert video

New Perspectives on Disease Modification in Atopic Dermatitis

Dermatology
An exploration into the concept and potential of disease modification through therapeutic interventions in AD.
View more
Exploring The Concept of Disease Modification in Atopic Dermatitis
expert video

Exploring The Concept of Disease Modification in Atopic Dermatitis

Dermatology
Exploring the concept ​of disease modification and related pathomechanisms ​in atopic dermatitis​.
View more
Can Early Intervention Shape the Course of Atopic Dermatitis?
expert video

Can Early Intervention Shape the Course of Atopic Dermatitis?

Dermatology
Exploring the concept ​of disease modification through early intervention with targeted systemic therapies in atopic dermatitis​.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: GreeceChange country/region